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 Most cases of candidiasis have been attributed to  C. albicans , but recently, non- Candida 
albicans Candida (NCAC) species have been identifi ed as common pathogens. The abil-
ity of  Candida species to form biofi lms has important clinical repercussions due to their 
increased resistance to antifungal therapy and the ability of yeast cells within the biofi lms 
to withstand host immune defenses. Given this clinical importance of the biofi lm growth 
form, the aim of this study was to characterize biofi lms produced by three NCAC spe-
cies, namely  C. parapsilosis, C. tropicalis and  C. glabrata . The biofi lm forming ability of 
clinical isolates of  C. parapsilosis ,  C. tropicalis and  C. glabrata recovered from different 
sources, was evaluated by crystal violet staining. The structure and morphological charac-
teristics of the biofi lms were also assessed by scanning electron microscopy and the bio-
fi lm matrix composition analyzed for protein and carbohydrate content. All NCAC species 
were able to form biofi lms although these were less extensive for  C. glabrata compared 
with  C. parapsilosis and  C. tropicalis . It was evident that  C. parapsilosis biofi lm produc-
tion was highly strain dependent, a feature not evident with  C. glabrata and  C. tropica-
lis . Scanning electron microscopy revealed structural differences for biofi lms with respect 
to cell morphology and spatial arrangement.  Candida parapsilosis biofi lm matrices had 
large amounts of carbohydrate with less protein. Conversely, matrices extracted from  C. 
tropicalis biofi lms had low amounts of carbohydrate and protein. Interestingly,  C. glabrata 
biofi lm matrix was high in both protein and carbohydrate content. The present work dem-
onstrates that biofi lm forming ability, structure and matrix composition are highly species 
dependent with additional strain variability occurring with  C. parapsilosis . 
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years, the number of infections caused by  Candida species 
has progressively increased [ 2 ]. This emergence is often 
associated with the increasing incidence of human immu-
nodefi ciency virus (HIV) infection [ 3 ], the rise in the 
elderly population base [ 4 ], a higher number of immuno-
compromised patients [ 5 ] and the more widespread use of 
indwelling medical devices [ 6 ,7 ]. 
 Although most cases of candidiases have been 
attributed to  Candida albicans , more recently, non- 
Candida albicans  Candida (NCAC) species ( Candida 
parapsilosis, Candida tropicalis and  Candida glabrata ) 
have been identifi ed as common pathogens. The prevalence 
of these species in human infection has been changing in 
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Introduction 
 Invasive fungal infections, such as candidiases, represent 
a public health problem of major importance [ 1 ].  Candida 
species normally exist as commensals but they are also 
opportunistic pathogens, with the ability to cause a vari-



































© 2009 ISHAM, Medical Mycology, 47, 681–689
 682 Silva et al.
recent years. In the 1980s, according to Kiehn  et al . [ 8 ], 
 C. albicans constituted 68% of  Candida isolates from sites 
other than blood in cancer patients, while  C. tropicalis, 
C. parapsilosis and  C. glabrata only accounted for 12.3, 
10.3 and 3.0% of isolates, respectively. Moreover, recently, 
60% of the fungemia cases reported by Bassetti  et al . [ 9 ] 
were due to NCAC species. 
 Candida tropicalis has emerged as the second or third most 
common agent of candidemia, mainly in oncology patients 
[ 10 ,11 ]. Moreover, the increased incidence of  C. tropicalis 
as a causative agent of nosocomial urinary tract infections 
has been reported [ 12 ].  Candida parapsilosis is generally 
regarded as one of the less virulent yeast species, although 
it is now a frequent cause of candidemia. Nosocomial out-
breaks of  C. parapsilosis have also been described and have 
been attributed to transfer of the yeast from the hands of 
healthcare workers [ 13 ].  Candida glabrata has recently 
emerged as an important nosocomial pathogen, yet little is 
known about its epidemiology [ 14 ].  Candida glabrata is of 
particular importance because of its innately high resistance 
to certain antifungal agents, specifi cally the azoles [ 15 ]. 
 One of the major contributions to  Candida virulence is 
its versatility in adapting to a variety of different habitats 
and the formation of surface-attached microbial commu-
nities known as biofi lms [ 16 ]. Biofi lm cells are organized 
into structured communities embedded within a matrix of 
extracellular material that is produced by the biofi lm cells 
[ 17 ]. Generally, the biofi lm matrix composition includes 
(in addition to water), carbohydrates, proteins, phosphorus, 
glucose and hexosamines. However, a large portion of 
the biofi lm matrix still remains to be identifi ed [ 18 ]. The 
formation of  Candida biofi lms has important clinical reper-
cussions because of their increased resistance to antifungal 
therapy and the protection afforded against host immune 
defenses [ 17 ,19 ]. 
 Many previous studies have focused on  C. albicans 
biofi lms [ 18, 20 – 24 ] due to its well-recognized virulence, 
whereas only few studies of biofi lms generated by all 
NCAC species have been reported [ 25 – 30 ]. Thus, the aims 
of this work were fi rstly to assess the biofi lm formation 
ability of clinical isolates of  C. glabrata ,  C. tropicalis and 
 C. parapsilosis recovered from different body sites, and 
secondly, to characterize the biofi lm structure and matrix 
composition in terms of protein and carbohydrate content. 
 Materials and methods 
 Organisms 
 A total of 18 clinical strains ( Table 1 ) of  C. tropicalis ,  C. 
glabrata and  C. parapsilosis , recovered from different body 
sites, were used in the course of this study. The majority 
of isolates were recovered from vaginal and urinary tract 
samples and were part of the collection at the Hospital of 
S. Marcos, Braga, Portugal.  C. tropicalis strains 12 and 
75 (recovered from the vaginal tract), were obtained from 
the archive collection of the University of Maringá, Brazil. 
All oral isolates were stock isolates of the biofi lm group of 
the Centre of Biological Engineering, and were originally 
isolated in the Clinic of Dentistry, Congregados, Portugal. 
Three reference strains of  C. tropicalis ,  C. glabrata and 
C. parapsilosis from the American Type Culture Collec-
tion (ATCC) were also examined. The identity of all isolates 
was confi rmed using CHROMagar Candida (CHROMagar, 
Paris, France) and by PCR-based sequencing using spe-
cifi c primers (ITS1 and ITS4) against the 5.8S subunit 
gene reference. Genomic DNA was extracted following 
previously described procedures [ 31 ]. The PCR products 
were sequenced using the ABI-PRISM Big Dye terminator 
cycle sequencing kit (Perkin Elmer, Applied Biosystems, 
Warrington, UK). 
 Growth conditions 
 For each experiment, strains were subcultured on Sabou raud 
dextrose agar (SDA) (Merck, Darmstadt, Germany) for 48 h 
at 37°C. Cells were then inoculated in Sabouraud dextrose 
broth (SDB) (Merck) and incubated for 18 h at 37°C under 
agitation at 120 rev/min. After incubation, the cells were 
harvested by centrifugation at 3000  g for 10 min at 4°C 
and washed twice with ultra-pure sterile water. Pellets were 
then suspended in SDB and the cellular density adjusted to 
1  10 7 cells ml −1 using a Neubauer counting chamber. 
 Biofi lm biomass quantifi cation 
 Standardized cell suspensions (200 μl containing 1  10 7 
cells ml −1 in SDB) were placed into selected wells of 96-well 
polystyrene microtiter plates (Orange Scientifi c, Braine-
l’Alleud, Belgium) and incubated at 37°C on a shaker at 
120 rev/min. At 24 h, 100 μl of SDB medium was removed 
and an equal volume of fresh SDB added. The preparations 
were then incubated for a further 48 h. After this step, the 
medium was aspirated and non-adherent cells removed by 
washing the biofi lms twice with sterile ultra-pure water. 
 Biofi lm forming ability was assessed through quanti-
fi cation of total biomass by crystal violet (CV) staining. 
Thus, after washing, biofi lms were fi xed with 200 μl of 
methanol, which was removed after 15 min of contact. The 
microtiter plates were allowed to dry at room temperature, 
and 200 μl of CV (1% v/v) added to each well and incu-
bated for 5 min. The wells were then gently washed with 
sterile, ultra-pure water and 200 μl of acetic acid (33% v/v) 
added to release and dissolve the stain. The absorbance of 
the obtained solution was read in triplicate in a microtiter 
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at 570 nm. Experiments were repeated as part of three to 
fi ve independent assays. 
 Biofi lm structure 
 To examine the structure of biofi lms by scanning elec-
tron microscopy 2 ml of the standardized cell suspension 
(1  10 7 cells ml −1 in SDB) was introduced into 24-well 
polystyrene plates (Orange Scientifi c) and incubated for 
48 h at 37°C and 120 rev/min. After 24 h, 1 ml of SDB 
medium was removed and an equal volume of fresh SDB 
added. At 48 h, the medium was aspirated and non-ad-
herent cells removed by washing the biofi lms twice with 
sterile ultra-pure water. Samples were dehydrated with 
alcohol (using 70% ethanol for 10 min, 95% ethanol for 
10 min and 100% ethanol for 20 min) and air dried for 20 
min. Samples were kept in a desiccator until the base of 
the wells was removed for analysis. Prior to observation, 
the bases of the wells were mounted onto aluminum stubs, 
sputter coated with gold and observed with an S-360 scan-
ning electron microscope (Leo, Cambridge, USA). 
 Biofi lm matrix composition 
 Extraction method .  Biofi lms for analysis of matrix mate-
rial were formed in 6-well polystyrene microtiter plates 
(Orange Scientifi c). For this, inocula of 3 ml of yeast cell 
suspension (1  10 7 cells ml −1 in SDB) were added to 
each well and biofi lms were formed as described previ-
ously. After 48 h, the biofi lm matrix was extracted using 
a slight modifi cation to a previously described protocol 
[ 32 ]. Briefl y, biofi lm samples were scraped from the 
6-well plates, resuspended with ultra-pure water, soni-
cated (Ultrasonic Processor, Cole-Parmer, Illinois, USA) 
for 30s at 30 W, and then the suspension was vortexed 
for 2 min. The suspension was centrifuged at 3000  g 
for 10 min at 4°C and the supernatant fi ltered through a 
0.2 μm nitrocellulose fi lter and stored at −20°C before 
analysis. The pellets were dried at 60°C until a constant 
dry biofi lm weight was determined. The experiments 
were performed in triplicate and in three independent 
assays. 
 Quantifi cation assays 
 Protein and carbohydrate quantifi cation .  The protein con-
tent of the biofi lm matrix was measured using the BCA 
Kit (Bicinchoninic Acid, Sigma-Aldrich, St Louis, USA), 
using bovine serum albumin (BSA) as the standard. 
 Total carbohydrate content of the biofi lm matrix was 
estimated according to the procedure of Dubois  et al . [ 33 ], 
using glucose as the standard. 
Table 1 Origin, reference and biofi lm matrix composition of non-Candida albicans Candida species. The values are means  standard deviations.
Matrix component (mg/g of biofi lm dry weight)
Species Origin Reference Protein Carbohydrate
C. parapsilosis Oral tract AD 35.9  7.2 748.8  43.8*
AM2 75.1  7.2* 926.8  144.9*
Urinary tract 534638 20.2  4.5* 263.7  13.2*
553877 46.8  16.6 592.6  93.4
Vaginal 491861 80.6  16.6* 555.2  238.5
513143 55.3  16.6 675.2  169.0
Reference ATCC 22019 42.2  10.3 516.4  219.1
C. tropicalis Oral tract AG1 46.3  3.5 22.2  5.8
T2.2 28.2  3.3* 21.5  4.0
Urinary tract 519468 34.2  9.3 15.7 1.9
544123 41.6  1.0 11.3  5.8
Vaginal 12 54.0  2.1* 58.7  7.4*
75 34.7  3.7 27.5  2.8
Reference ATCC 750 64.6  18.2* 15.5  2.8
C. glabrata Oral tract D1 325.2  31.4 572.8  111.2
AE2 226.7  84.1 241.8  52.2
Urinary tract 562123 181.7  28.7 409.5  112.4
513100 226.5  59.3 233.7  88.5
Vaginal 534784 136.4  38.5 398.3  130.8
585626 246.9  47.5 742.6  285.2*
Reference ATCC 2001 243.6  30.7 420.3  39.2
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differences were found in the extent of biofi lm formation 
for all the  C. tropicalis strains ( P  0.05), with the excep-
tion of strain 12, which had the highest biofi lm forming 
ability (Abs = 2.65 r 0.13) ( P  0.001). This strain produced 
a two-fold greater level of biofi lm than other strains of 
 C. tropicalis and  C. parapsilosis , and a fi ve-fold increase 
over  C. glabrata strains. 
 For each species, strains originating from the urinary 
tract generally yielded lower biofi lm levels compared with 
those from other body sites. In the case of  C. parapsilosis, 
oral isolates were the highest biofi lm producers and for 
the other NCAC species studied, the highest biofi lm 
producers were vaginal isolates ( C. glabrata 534784 and 
 C. tropicalis 12). 
 Structure of non-Candida albicans Candida species biofi lms 
 SEM analysis was used to examine biofi lm structure 
and to determine  Candida morphological characteristics 
( Fig. 2 ). 
 Mature biofi lms of  C. parapsilosis and  C. tropicalis 
strains consisted of a dense network of cells of a variety 
of morphologies. Biofi lms of  C. parapsilosis strains AD, 
553877 and ATCC 22019 were composed of both yeasts and 
pseudohyphae, although biofi lms formed by other strains of 
the same species were devoid of pseudohyphae ( Fig. 2 A). 
Biofi lms formed by  C. tropicalis exhibited only yeast mor-
phology, with exception of strains AG1 and 12 which pre-
sented hyphal forms, with the latter appearing as especially 
long fi laments ( Fig. 2 B). All biofi lms of  C. glabrata strains 
were comprised only of yeasts ( Fig. 2 C). 
 Statistical analysis 
 Results were compared using One-Way analysis of vari-
ance (ANOVA) by applying Levene’s test of homogeneity 
of variance and the Tukey multiple-comparisons test, using 
SPSS software (SPSS [Statistical Package for the Social 
Sciences], Inc., Chicago, USA). All tests were performed 
with a confi dence level of 95%. 
 Results 
 Biofi lm forming ability by non-Candida albicans Candida 
species 
 Figure 1 presents the results of biofi lm quantifi cation using 
CV staining. It was evident that all NCAC species formed 
biofi lms, although differences occurred depending on spe-
cies or strain as in the case of  C. parapsilosis . Importantly, 
it was noticed that generally  C. glabrata biofi lms had less 
total biomass (average Abs = 0.53  0.22) compared with  C. 
parapsilosis (average Abs = 1.14  0.43) and  C. tropicalis 
(average Abs = 1.31  0.08). 
 Candida glabrata strains had similar biofi lm forming 
ability with no signifi cant strain differences ( P  0.05). 
In contrast,  C. parapsilosis strains were heterogeneous in 
terms of the level of biofi lm formation. Biofi lms formed by 
 C. parapsilosis AD yielded the highest level of absorbance 
(Abs = 1.84  0.34) which were statistically higher than for 
 C. parapsilosis 534638 ( P = 0.004), 553877 ( P  0.001) and 
ATCC 22019 ( P  0.001).  Candida tropicalis strains exhib-
ited a more homogeneous behavior with all strains being 
high biofi lm formers (Abs values 0.75). No statistical 
Fig. 1  Absorbance values of Crystal Violet solu-
tions (Abs CV) obtained from 48 h biofi lms of 
non-Candida albicans Candida species formed in 
SDB ( l=570 nm) from different origins ( oral, 
urinary and vaginal). Error bars represent stan-
dard deviation. *Strains that are signifi cantly differ-
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Fig. 2  Scanning electron microscopy of non-Candida albicans Candida species biofi lms formed in SDB at 48 h. (A) C. parapsilosis, (B) C. tropicalis 
and (C) C. glabrata clinical isolate strains. Arrows indicate the presence of hyphal morphologies. The bar in the images corresponds to 20 μm. 
Magnifi cation  1000.
 In the case of  C. parapsilosis biofi lm structure ( Fig. 2 A), 
strains AD, AM2, 534638 and 513143 formed a multilayer 
and compact biofi lms covering the entire surface. In con-
trast, biofi lms of strains 553877, 491861 and ATCC 22019, 
consisted of non-contiguous cell aggregates. The structure 
of  C. tropicalis ( Fig. 2 B) biofi lms was also strain depen-
dent with some strains (AG1, T2.2, 12, 75 and ATCC 750) 
producing thick biofi lms of co-aggregated cells and others 
(strain 519468 and 544123) yielding a more discontinuous 
monolayer of yeasts anchored to surface.  Candida glabrata 
( Fig. 2 C) revealed either a multilayer biofi lm structure inti-
mately packed (strains 562123 and 513100) or constituted 
by clusters of cells (strains D1, AE2, 534784, 585626 and 
ATCC 2001). 
 The biofi lm structures for isolates from the same clini-
cal origin were similar for  C. glabrata strains ( Fig. 2 C). 
Biofi lms formed by the urinary isolates (562123 and 
513100) displayed a highly compact layer covering the 
entire surface in a ‘carpet’ like appearance. Biofi lms of 
oral isolates (D1 and AE2) revealed smaller clusters com-
pared to those in biofi lms of vaginal isolates (534784 and 
585626). Biofi lms of oral  C. parapsilosis strains ( Fig. 2 A) 
(AD and AM2) were very similar, presenting a multilayer 
structure. In the case of  C. tropicalis ( Fig. 2 B) urinary iso-
lates (519468 and 544123), the biofi lms were also similar, 
presenting as discontinuous monolayers. 
 Matrix biofi lm composition 
 Table 1 shows the yield of total protein and carbohy-
drates extracted from biofi lms formed by the NCAC 
species studied. The results showed that generally  C. 
parapsilosis biofi lm matrices had high amounts of carbo-
hydrate (average mg/g biofi lm dry  weight = 611.2  206.5) and 
relatively lower amounts of proteins (average mg/g biofi lm 
dry  weight = 50.9  21.4). Strain differences were evident in 
terms of both protein and carbohydrate contents, with C . 
parapsilosis AM2 having a statistically higher carbohydrate 
and protein content in its biofi lm matrix as compared with 
the all other  C. parapsilosis strains, except strain 491861 
(the highest protein content) and strain AD (similar to AM2 
in carbohydrate content). 
 In contrast, compared with the other species, the 
biofi lm matrices of  C. tropicalis strains had lower 
concentrations of both protein (average mg/g  biofi lm dry 
weight = 43.4  12.7) and carbohydrates (average mg/g  bio-
fi lm  dry weight = 24.6  15.9). Despite statistical differences 
being evident between C . tropicalis strains, the relatively 
low protein and carbohydrate matrix composition was a 
consistent fi nding for  C. tropicalis . 
 Interestingly, biofi lm matrices of  C. glabrata had rela-
tively higher quantities of both protein (average mg/g  bio-
fi lm  dry  weight = 226.7  58.6) and carbohydrate (average mg/g 
 biofi lm  dry  weight = 431.3  179.6) compared with the other 
species. Indeed, protein levels were on average fi ve times 
higher than those of  C. parapsilosis and  C. tropicalis . 
 No correlation was found concerning the amount of 
carbohydrate and protein extracted from biofi lm of NCAC 
species and the respective source of each clinical iso-
late. However, the biofi lm matrix of the vaginal clinical 
isolate,  C. tropicalis 12, presented the highest amount 
of protein and carbohydrate of all clinical isolates of  C. 
tropicalis . For  C. parapsilosis , oral isolates (AD and AM2) 
had the highest quantity of carbohydrates and the urinary 
isolate,  C. parapsilosis 534638, the lowest protein and 
carbohydrate content. 
 Discussion 
 Biofi lm forming ability may confer NCAC species with 
an ecological advantage, aiding survival as commensals 
and pathogens of humans by allowing them to evade host 
immune mechanisms, resisting antifungal treatment, and 
withstanding the competitive pressure from other micro-
organisms. Biofi lm formation in NCAC species, besides 
possibly being a key factor for the survival of these spe-
cies, may also be responsible for them being particularly 
well adapted to colonization of tissues and indwelling 
devices. 
 In the present study, the biofi lm formation ability of dif-
ferent clinical isolates of NCAC species was evaluated and 
the results ( Fig. 1 ) showed that all NCAC species studied 
( C. tropicalis ,  C. parapsilosis and  C. glabrata ) , formed 
biofi lms on polystyrene surfaces under the assayed condi-
tions, although to different extents depending on the spe-
cies and strain. These results were in agreement with those 
of other authors, who reported that biofi lm formation by 
 Candida species occurs on a number of abiotic surfaces, 
including polystyrene [ 24 – 26 , 34 ]. Signifi cant statistical 
differences were found for biofi lm production by the NCAC 
species in SDB medium. In fact,  C. glabrata strains were, 
in general, less able to form biofi lms than  C. parapsilosis 
and  C. tropicalis strains. These results are in accordance 
with Shin  et al . [ 26 ] who reported that biofi lm positivity 
occurred most frequently in isolates of  C. tropicalis , 
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a thick extracellular polymeric layer. In fact, almost all 
microorganisms display structural heterogeneity within 
their biofi lm architecture [ 38 ]. The present work indicates 
that this heterogeneity appears to be common in biofi lms 
formed by  C. glabrata ,  C. tropicalis and  C. parapsilosis 
strains, revealing new important aspects on NCAC species 
biofi lm ultrastructure. 
 One of the most important characteristics of both bacte-
rial and fungal biofi lms is the presence and composition 
of the extracellular matrix [ 17 ,28 ]. There is a general con-
sensus that the biofi lm matrix acts as a barrier to diffusion 
of antimicrobial agents, thereby limiting access of antimi-
crobials to organisms at the base of the biofi lm [ 39 ]. In 
this study, biofi lm matrices were analyzed for carbohydrate 
and protein content. Signifi cantly, consistent differences 
were found in the composition of biofi lms of the NCAC 
species. Matrices isolated from  C. parapsilosis biofi lms 
consisted of high amounts of carbohydrates and small 
amounts of proteins, whilst  C. tropicalis biofi lms were low 
in both carbohydrate and protein content. These results are 
in accordance with previous work [ 28 ] on  C. tropicalis 
biofi lm matrices which that they were mainly composed 
of hexosamine, with smaller amounts of carbohydrate and 
proteins. To the authors’ knowledge, this is the fi rst report 
on the analysis of the biofi lm matrices of  C. parapsilosis 
and  C. glabrata . Interestingly, the matrices recovered from 
 C. glabrata strains had higher amounts of both proteins 
and carbohydrates. This is an interesting result, especially 
when related to potential virulence of this species whose 
infections yield both the highest mortality rate [ 40 ] and 
resistance to antifungal agents [ 15 ]. 
 The three different sources (body sites) for the clinical 
isolates represent very diverse ecological niches and dif-
fer in many biotic and abiotic factors. Recent reports have 
demonstrated that blood isolates produce greater quantities 
of biofi lm compared with oral isolates [ 41 ]. In this current 
study, no correlation was found in terms of biofi lm forming 
ability and matrix composition with the origin of the iso-
late. However, biofi lm structure analysis did highlight some 
interesting aspects. For  C. glabrata , the biofi lm structure 
for isolates from the same origin did appear to be similar. 
This was also true for  C. tropicalis urinary tract isolates. 
It could readily be hypothesized that for certain body sites, 
colonization requires a particular phenotype with respect 
to biofi lm formation. Such a biofi lm phenotype might be 
genetically rather than environmentally governed, thus 
explaining why the biofi lm structural differences could be 
detected in these  in vitro studies. Through elucidating such 
inherent differences, it might be possible to identify and 
specifi cally combat strains adapted for infection at particu-
lar body sites. It must be emphasized, however, that further 
investigations with isolates from specifi c environments are 
required to confi rm this hypothesis. 
 It was noted that the biofi lm forming ability of 
 C. parapsilosis species was highly strain dependent, which 
was less evident with both  C. glabrata and  C. tropicalis . 
These observations corroborate previous reports for 
C. albicans whose growth and virulence attributes, together 
with biofi lm formation [ 23 ,25 ] have been shown to be 
highly strain dependent. Such fi ndings undoubtedly 
refl ect inherent physiological differences between strains 
and could have signifi cance with respect to pathogenic 
potential. 
 Despite the inherently destructive nature of SEM pro-
cessing, the method provided useful information on biofi lm 
structure and on the different cellular morphologies. It is 
known that biofi lm structure is dependent on environmen-
tal factors including growth conditions, nature of colonized 
surface [ 22 ,25, 29 ] and importantly from the perspective 
of this present study, the microbial species and strains 
involved [ 22 ,25 , 29, 34, 35 ]. SEM did indeed reveal struc-
tural and morphological differences for the biofi lms of the 
studied NCAC species and strains. Biofi lms of  C. glabrata 
( Fig. 2 C) presented as a multilayered structure with blasto-
conidia intimately packed, for some strains, and for others 
as a biofi lm composed of cell clusters. As expected, there 
was a total absence of pseudohyphae and hyphae since 
 C. glabrata is a non-hyphal species. Recently, Zaw  et al . 
[ 36 ] also reported that after 48 h, the biofi lms of aerobi-
cally grown  C. glabrata generally revealed a multilayer 
structure packed with blastoconidia devoid of pseudohy-
phae and hyphae. In the presented study , C. parapsilosis 
strains ( Fig. 2 A) yielded a multilayer biofi lm structure 
that was comprised of a dense network of yeasts and 
pseudohyphae. Although few studies on the biofi lm struc-
ture of  C. parapsilosis strains have been reported, Kuhn 
 et al . [ 35 ] described that  C. parapsilosis biofi lms con-
sisted of irregular groupings of blastoconidia on a basal 
blastoconidia layer. Regarding  C. tropicalis , its biofi lms 
appeared as discontinuous layers of large blastoconidia 
anchored to the surface, which was in accordance with 
the fi ndings of Bizerra  et al . [ 30 ]. The latter also reported 
that  C. tropicalis biofi lms formed in SDB medium, con-
tained only blastoconidia or generated a multilayer het-
erogeneous structure covering the entire surface as a thick 
biofi lm. In the present study, large quantities of hyphal 
elements were found in strain  C. tropicalis 12 biofi lms 
(vaginal clinical isolate). It has been suggested [ 21 ,37 ] 
that the presence of such hyphae may have importance 
in the structural integrity of multilayered biofi lms. The 
present study reinforces and emphasizes a previous study 
where one  C. tropicalis strain formed a thin layer of hyphae 
(in YNB) compared with other strains only presenting 
blastoconidia [ 35 ]. Parahitiyawa  et al . [ 34 ], reported that 
on polystyrene surfaces,  C. tropicalis biofi lms consisted 
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